Upregulated SPAG6 correlates with increased STAT1 and is associated with reduced sensitivity of interferon‐α response in BCR::ABL1 negative myeloproliferative neoplasms

Li Ding,Jie Luo,Juan Du,Beibei Zhao,Jin Luo,Shirui Pan,Linyi Zhang,Xinyu Yan,Junnan Li,Lin Liu
DOI: https://doi.org/10.1111/cas.15950
IF: 5.7
2023-09-10
Cancer Science
Abstract:We clarified for the first time that sperm‐associated antigen 6 (SPAG6) is significantly upregulated in myeloproliferative neoplasm (MPN)‐derived leukemia cells and regulated by signal transducer and activator of transcription 1 (STAT1), showing pro‐oncogenic activity. Downregulation of SPAG6 could impair autocrine function of inflammatory cytokines, reduce reactivation of the JAK‐STAT pathway, and sensitize interferon‐α response through enhancing the induction level of STAT1 in MPN. Sperm‐associated antigen 6 (SPAG6) has been identified as an oncogene or tumor suppressor in various types of human cancer. However, the role of SPAG6 in BCR::ABL1 negative myeloproliferative neoplasms (MPNs) remains unclear. Herein, we found that SPAG6 was upregulated at the mRNA level in primary MPN cells and MPN‐derived leukemia cell lines. The SPAG6 protein was primarily located in the cytoplasm around the nucleus and positively correlated with β‐tubulin expression. In vitro, forced expression of SPAG6 increased cell clone formation and promoted G1 to S cell cycle progression. Downregulation of SPAG6 promoted apoptosis, reduced G1 to S phase transition, and impaired cell proliferation and cytokine release accompanied by downregulated signal transducer and activator of transcription 1 (STAT1) expression. Furthermore, the inhibitory effect of interferon‐α (INF‐α) on the primary MPN cells with high SPAG6 expression was decreased. Downregulation of SPAG6 enhanced STAT1 induction, thus enhancing the proapoptotic and cell cycle arrest effects of INF‐α both in vitro and in vivo. Finally, a decrease in SPAG6 protein expression was noted when the STAT1 signaling was blocked. Chromatin immunoprecipitation assays indicated that STAT1 protein could bind to the SPAG6 promoter, while the dual‐luciferase reporter assay indicated that STAT1 could promote the expression of SPAG6. Our results substantiate the relationship between upregulated SPAG6, increased STAT1, and reduced sensitivity to INF‐α response in MPN.
oncology
What problem does this paper attempt to address?